Compounds known to be potent against a specific protein target may potentially contain a signature profile of common substructures that is highly correlated to their potency. These substructure profiles may be useful in enriching compound libraries or for prioritizing compounds against a specific protein target. With this objective in mind, a set of compounds with known potency against six selected kinases (2 each from 3 kinase families) was used to generate binary molecular fingerprints. Each fingerprint key represents a substructure that is found within a compound and the frequency with which the fingerprint occurs was then tabulated. Thereafter, the concept of Correlation Rules was applied with the aim of uncovering substructures that a...
Protein kinases have emerged as one of the major drug target classes that are amenable to the develo...
The identification and design of selective compounds is important for the reduction of unwanted side...
In early-stage drug discovery, the hit-to-lead optimization (or "hit expansion") stage entails start...
Key-based substructural fingerprints are an important element of computer-aided drug design techniqu...
Substructure mining is a well-established technique used frequently in drug discovery. Its aim is to...
Understanding the structure–activity relationships (SARs) of small molecules is important for develo...
For kinase inhibitors, X-ray crystallography has revealed different types of binding modes. Currentl...
AbstractClassifying proteins into functionally distinct families based only on primary sequence info...
Drug discovery programs frequently target members of the human kinome and try to identify small mole...
AbstractBackground: There are many ways to represent a molecule's properties, including atomic-conne...
Molecular target identification is of central importance to drug discovery. Here, we developed a com...
<div><p>The protein kinases are a large family of enzymes that play fundamental roles in propagating...
Motivation: Certain chemical substructures are present in many drugs. This has led to the claim of ‘...
Protein structure determination of soluble globular protein domains has developed into an efficient ...
A current key feature in drug-target network is that drugs often bind to multiple targets, known as ...
Protein kinases have emerged as one of the major drug target classes that are amenable to the develo...
The identification and design of selective compounds is important for the reduction of unwanted side...
In early-stage drug discovery, the hit-to-lead optimization (or "hit expansion") stage entails start...
Key-based substructural fingerprints are an important element of computer-aided drug design techniqu...
Substructure mining is a well-established technique used frequently in drug discovery. Its aim is to...
Understanding the structure–activity relationships (SARs) of small molecules is important for develo...
For kinase inhibitors, X-ray crystallography has revealed different types of binding modes. Currentl...
AbstractClassifying proteins into functionally distinct families based only on primary sequence info...
Drug discovery programs frequently target members of the human kinome and try to identify small mole...
AbstractBackground: There are many ways to represent a molecule's properties, including atomic-conne...
Molecular target identification is of central importance to drug discovery. Here, we developed a com...
<div><p>The protein kinases are a large family of enzymes that play fundamental roles in propagating...
Motivation: Certain chemical substructures are present in many drugs. This has led to the claim of ‘...
Protein structure determination of soluble globular protein domains has developed into an efficient ...
A current key feature in drug-target network is that drugs often bind to multiple targets, known as ...
Protein kinases have emerged as one of the major drug target classes that are amenable to the develo...
The identification and design of selective compounds is important for the reduction of unwanted side...
In early-stage drug discovery, the hit-to-lead optimization (or "hit expansion") stage entails start...